Charles Sternberg, Associate Editor08.03.23
The Producto Group, led by CEO, Mark Rauenzahn, is a portfolio company of Culper Capital Partners that is hyper focused on organic growth, while continuing to seek out add-ons to bolster their service offerings.
The Company’s executive management team is rounded out with its COO, Mike Duquette who has over 35+ years in medical device molding and contract assembly operations, and CFO Jennifer Brochu, most recently with Ametek, with over 30 years of experience in finance and a proven track record of driving financial success and operational excellence.
CEO, Mark Rauenzahn states, "We are thrilled about the makeup of our leadership team at Producto. The Producto team is poised to propel the company to new heights.”
Producto has also assembled a MedTech centric Board of Directors, to drive its Producto Medical initiative, which includes Dean Schauer, CEO and President of Confluent Medical Technologies, Declan Smyth, President of Franchise at Viant Medical and Adam Cook, co-founder and Chief Investment Officer of Culper Capital Partners and former majority owner and CEO of Glebar Company. With industry veterans on the board, Producto Medical gains an invaluable resource that perfectly aligns with its mission of becoming a strategic and acquisitive manufacturing leader in the medical device industry.
Cook remarks, "The addition of Declan and Dean's leadership and extensive industry knowledge will significantly differentiate our capabilities and propel us closer to achieving our goals at Producto."
As part of a fully integrated “One Producto” solution, Producto Medical offers a diverse range of precision tooling, complex machining and heavy-gauge plastic enclosures for the medical device industry. The Company has differentiated capabilities including the manufacture of ultra-precision long drawn round tooling for injection molds, including FDA mandated ISO Luer and syringe tooling, heavy gauge plastic enclosures for a variety of medical device and biotech applications and precision machining and subassembly for a variety of medical device applications.
The Company’s executive management team is rounded out with its COO, Mike Duquette who has over 35+ years in medical device molding and contract assembly operations, and CFO Jennifer Brochu, most recently with Ametek, with over 30 years of experience in finance and a proven track record of driving financial success and operational excellence.
CEO, Mark Rauenzahn states, "We are thrilled about the makeup of our leadership team at Producto. The Producto team is poised to propel the company to new heights.”
Producto has also assembled a MedTech centric Board of Directors, to drive its Producto Medical initiative, which includes Dean Schauer, CEO and President of Confluent Medical Technologies, Declan Smyth, President of Franchise at Viant Medical and Adam Cook, co-founder and Chief Investment Officer of Culper Capital Partners and former majority owner and CEO of Glebar Company. With industry veterans on the board, Producto Medical gains an invaluable resource that perfectly aligns with its mission of becoming a strategic and acquisitive manufacturing leader in the medical device industry.
Cook remarks, "The addition of Declan and Dean's leadership and extensive industry knowledge will significantly differentiate our capabilities and propel us closer to achieving our goals at Producto."
As part of a fully integrated “One Producto” solution, Producto Medical offers a diverse range of precision tooling, complex machining and heavy-gauge plastic enclosures for the medical device industry. The Company has differentiated capabilities including the manufacture of ultra-precision long drawn round tooling for injection molds, including FDA mandated ISO Luer and syringe tooling, heavy gauge plastic enclosures for a variety of medical device and biotech applications and precision machining and subassembly for a variety of medical device applications.